Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001418 · ClinicalTrials.gov registry record

PET Scan in Patients With Neurocardiologic Disorders

A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
335
Enrollment target

NCT00001418: Completed study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

NCT00001418 is a clinical trial that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 335 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001418 has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
335 participants
Enrollment target

Study Summary

This study is designed to use PET scans in order to measure activity of the sympathetic nervous system. The sympathetic nervous system is the portion of the nervous system that maintains a normal supply of blood and fuel to organs during stressful situations. PET scan or Positron Emission Tomography is an advanced form of an X-ray. It is used to detect radioactive substances in the body. During this study researchers plan to inject small amounts of the radioactive drug fluorodopamine into patients. Fluorodopamine is very similar to the chemicals found in the sympathetic nervous system. It can attach to sympathetic nerve endings and allow researchers to view them with the aid of a PET scan. One area of the body with many sympathetic nerve endings is the heart. After giving a dose of fluorodopamine, researchers will be able to visualize all of the sympathetic nerve endings involved in the activity of the heart. In addition, this diagnostic test will help researchers detect abnormalities of the nervous system of patient's hearts.

Trial Details

FieldValue
Enrollment Target 335 participants
Start Date 1994-07
Est. Completion 2004-08

What the finished NCT00001418 record still lists

NCT00001418 is an observational study that tracks outcomes without assigning an intervention. The registered 335 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00001418 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00001418 about?

NCT00001418 is a clinical study titled "PET Scan in Patients With Neurocardiologic Disorders". This study is designed to use PET scans in order to measure activity of the sympathetic nervous system. The sympathetic nervous system is the portion of the nervous system that maintains a normal supply of blood and fuel to organs during stressful situations. PET scan or Positron Emission Tomograph...

What is the current status of trial NCT00001418?

This trial is currently completed. The enrollment target is 335 participants. The study started on 1994-07. Estimated completion is 2004-08.

Who is sponsoring clinical trial NCT00001418?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04134754 · 335 participants · NA

    Carbon Dioxide (CO2) Chemosensitivity and SUDEP

  • NCT05554406 · 335 participants · Phase 2

    Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

  • NCT06183437 · 335 participants · Phase 4

    The STOP-MED CTRCD Trial

  • NCT06885177 · 335 participants · NA

    TECTONIC CAD IVL IDE Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00001418, the US trial registry maintained by the National Library of Medicine. NCT00001418 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.